← Open Payments lookup

MICHAEL EVANS: Open Payments

NPI 1790188910 · LAYTON, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,059 in 65 payments from 17 companies in 2025. Trend: 2023 $694 · 2024 $1,012 · 2025 $1,059

Food & beverage: $1,059
CompanyPaymentsAmount
ABBVIE INC.25$351
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)5$104
Axsome Therapeutics, Inc.6$103
PFIZER INC.4$83
Lilly USA, LLC5$80
HARMONY BIOSCIENCES LLC3$49
Salix Pharmaceuticals, a division of Bausch Health US, LLC3$45
Boehringer Ingelheim Pharmaceuticals, Inc.2$41
GlaxoSmithKline, LLC.2$35
AstraZeneca Pharmaceuticals LP2$34

Products named: VRAYLAR, CAPLYTA, QULIPTA, NURTEC ODT, UBRELVY, MOUNJARO, Auvelity, WAKIX.

Industry payments across UT — which companies pay providers there.